|
Objectives of the Genomics Policy Executive Course |
| To familiarize participants with the current status and implications of health genomics/biotechnology, and to provide information relevant to public policy on health genomics/biotechnology |
| To provide frameworks for analyzing and debating the policy issues and related ethical questions in health genomics/biotechnology, and to help understand, anticipate and possibly influence the legal and regulatory frameworks under which health biotechnology industries will operate, both nationally and internationally |
| To begin developing an opinion-leaders network across different sectors (industry, academic, government, NGOs) by sharing perspectives and building relationship |
| To formulate recommendations for future policy and strategic directions at the regional, national and individual levels. |
Acharya et al. Health Research Policy and Systems 2005 3:1 doi:10.1186/1478-4505-3-1 |